Suppr超能文献

用于生成无整合诱导多能干细胞的非病毒方法。

Non-viral methods for generating integration-free, induced pluripotent stem cells.

作者信息

Deng Xiao-Yue, Wang Hu, Wang Tao, Fang Xian-Tao, Zou Li-Li, Li Zhi-Ying, Liu Chang-Bai

出版信息

Curr Stem Cell Res Ther. 2015;10(2):153-8. doi: 10.2174/1574888x09666140923101914.

Abstract

Induced pluripotent stem (iPS) cells were created from mouse fibroblasts by induced expression of Yamanaka factors, Oct3/4, Sox2, Klf4, and c-Myc. This technique has quickly resulted in an exponential increase in the amount of pluripotency studies, and has provided a valuable tool in regenerative medicine. At the same time, many methodologies to generate iPS cells have been reported, and are comprised mainly of viral methods and non-viral methods. Although viral methods may not be applicable for clinical applications, various nonviral methods have been reported in recent years, including DNA vector-based approaches, transfection of mRNA, transduction of reprogramming proteins, and use of small molecule compounds. This review summarizes and evaluates these non-viral methods.

摘要

通过诱导表达山中因子(Oct3/4、Sox2、Klf4和c-Myc)从小鼠成纤维细胞中产生了诱导多能干细胞(iPS细胞)。这项技术迅速导致多能性研究数量呈指数级增长,并为再生医学提供了一个有价值的工具。与此同时,已经报道了许多产生iPS细胞的方法,主要包括病毒方法和非病毒方法。尽管病毒方法可能不适用于临床应用,但近年来已经报道了各种非病毒方法,包括基于DNA载体的方法、mRNA转染、重编程蛋白转导以及小分子化合物的使用。本综述总结并评估了这些非病毒方法。

相似文献

1
Non-viral methods for generating integration-free, induced pluripotent stem cells.
Curr Stem Cell Res Ther. 2015;10(2):153-8. doi: 10.2174/1574888x09666140923101914.
2
Generation of transgene-free induced pluripotent stem cells with non-viral methods.
Chin Med Sci J. 2013 Mar;28(1):50-4. doi: 10.1016/s1001-9294(13)60019-x.
3
Chick derived induced pluripotent stem cells by the poly-cistronic transposon with enhanced transcriptional activity.
J Cell Physiol. 2018 Feb;233(2):990-1004. doi: 10.1002/jcp.25947. Epub 2017 May 24.
4
Advances in reprogramming somatic cells to induced pluripotent stem cells.
Stem Cell Rev Rep. 2010 Sep;6(3):367-80. doi: 10.1007/s12015-010-9123-8.
5
Emerging methods for preparing iPS cells.
Jpn J Clin Oncol. 2012 Sep;42(9):773-9. doi: 10.1093/jjco/hys108. Epub 2012 Jul 23.
7
Virus-free induction of pluripotency and subsequent excision of reprogramming factors.
Nature. 2009 Apr 9;458(7239):771-5. doi: 10.1038/nature07864. Epub 2009 Mar 1.
8
A Versatile In Vivo System to Study Myc in Cell Reprogramming.
Methods Mol Biol. 2021;2318:267-279. doi: 10.1007/978-1-0716-1476-1_14.
10
Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. doi: 10.2174/187152711795563994.

引用本文的文献

2
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations.
Hum Gene Ther. 2025 Mar;36(5-6):597-617. doi: 10.1089/hum.2024.191. Epub 2025 Feb 11.
3
Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies.
ACS Pharmacol Transl Sci. 2024 Jul 17;7(8):2306-2325. doi: 10.1021/acsptsci.4c00284. eCollection 2024 Aug 9.
4
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.
ACS Pharmacol Transl Sci. 2024 Jan 2;7(1):72-96. doi: 10.1021/acsptsci.3c00324. eCollection 2024 Jan 12.
5
Emerging Landscape of Preclinical Models for Studying COVID-19 Neurologic Diseases.
ACS Pharmacol Transl Sci. 2023 Sep 6;6(10):1323-1339. doi: 10.1021/acsptsci.3c00127. eCollection 2023 Oct 13.
6
Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration.
Pathophysiology. 2023 Aug 2;30(3):346-365. doi: 10.3390/pathophysiology30030027.
7
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.
Curr Med Chem. 2024;31(13):1646-1690. doi: 10.2174/0929867330666230503144619.
8
Review on kidney diseases: types, treatment and potential of stem cell therapy.
Ren Replace Ther. 2023;9(1):21. doi: 10.1186/s41100-023-00475-2. Epub 2023 Apr 27.
9
Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems.
Cells. 2023 Mar 18;12(6):930. doi: 10.3390/cells12060930.

本文引用的文献

1
OCT4: A penetrant pluripotency inducer.
Cell Regen. 2014 Mar 31;3(1):6. doi: 10.1186/2045-9769-3-6. eCollection 2014.
2
Characterization of a novel cell penetrating peptide derived from human Oct4.
Cell Regen. 2014 Jan 31;3(1):2. doi: 10.1186/2045-9769-3-2. eCollection 2014.
3
Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules.
Biomaterials. 2014 Aug;35(26):7336-45. doi: 10.1016/j.biomaterials.2014.05.015. Epub 2014 Jun 2.
5
Vectorology and factor delivery in induced pluripotent stem cell reprogramming.
Stem Cells Dev. 2014 Jun 15;23(12):1301-15. doi: 10.1089/scd.2013.0621. Epub 2014 Apr 16.
8
Dissecting the roles of miR-302/367 cluster in cellular reprogramming using TALE-based repressor and TALEN.
Stem Cell Reports. 2013 Aug 15;1(3):218-25. doi: 10.1016/j.stemcr.2013.07.002. eCollection 2013.
10
Deterministic direct reprogramming of somatic cells to pluripotency.
Nature. 2013 Oct 3;502(7469):65-70. doi: 10.1038/nature12587. Epub 2013 Sep 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验